Clinical Trial
Evaluation of Digoxin for Relapsed Non-WNT, Non-SHH Medulloblastoma
Cancer Type
Siteman Kids- Pediatrics
Protocol Number
202411154
Principal Investigator
Learn more about this study at
clinicaltrials.gov
For more information contact us here:
Phone
800-600-3606Brief Summary
The purpose of this study is to evaluate the efficacy of digoxin in treating relapsed non-SHH, non-WNT medulloblastoma in pediatric and young adult patients.
Protocol Interventions
Drug: Digoxin
Learn About Clinical Trials
Clinical trials are research studies that help us find new ways to prevent, diagnose, and treat cancer. If you are interested in participating in a clinical trial, our team will help you find a study that is right for you. Call us to speak with a Siteman care coordinator.